Efficacy of senna versus lactulose in terminal cancer patients treated with opioids

Journal of Pain and Symptom Management
Y AgraM J Calvo

Abstract

The best laxative for terminal cancer patients treated with opioids still remains to be determined. This comparative study was conducted with the objective of determining treatment and cost efficiency for senna and lactulose in terminal cancer patients treated with opioids. The methodology used a randomized, open, parallel group design. The study was conducted in the Palliative Care Unit in one Madrid Health Care District. Ninety-one terminal cancer patients were randomized into two groups: A = treated with senna (starting with 0.4 mL daily), and B = treated with lactulose (starting with 15 mL daily) for a 27-day period. The main outcome measures were defecation-free intervals of 72 hr, days with defecation, general health status, and treatment cost. Laxative efficacy was analyzed through t test and analysis of variance. No difference was found between the laxatives in defecation-free intervals or in days with defecation. The final scores for general health status were similar in both groups. Given that the two treatments have similar efficacy and adverse effects, a recommendation is made for the use of senna because its cost is lower than lactulose.

References

Jan 1, 1992·Pharmacology
Dec 31, 1981·The New England Journal of Medicine·L C MaguireE Miller
Apr 1, 1995·Palliative Medicine·J E EllershawL C Boys

❮ Previous
Next ❯

Citations

Oct 4, 2011·European Journal of Clinical Pharmacology·Annabella VitaloneGabriela Mazzanti
Dec 21, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S WirzJ Nadstawek
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Ewan McNicolUNKNOWN Americal Pain Society
Apr 25, 2006·Journal of Palliative Medicine·Shalini DalalEduardo Bruera
May 6, 2008·Journal of Palliative Medicine·Philippa Helen Hawley, Jai Jun Byeon
Oct 22, 2011·Journal of Palliative Medicine·Ernesto VignaroliEduardo Bruera
Feb 12, 2002·Pharmacotherapy·Christopher M HerndonPamala A Hallin
Jan 18, 2012·Journal of Pain and Symptom Management·Robert TwycrossAndrew Wilcock
Aug 28, 2007·The American Journal of Geriatric Pharmacotherapy·Ellina K MaxIlene H Zuckerman
Mar 23, 2007·Journal of Surgical Oncology·Julie Silver, R Samuel Mayer
Mar 22, 2012·Journal of Dietary Supplements·Catherine UlbrichtMinney Varghese
Oct 10, 2007·Clinics in Geriatric Medicine·John E Morley
Oct 8, 2008·Palliative Medicine·P J LarkinUNKNOWN European Consensus Group on Constipation in Palliative Care
Nov 12, 2015·Therapeutic Advances in Gastroenterology·Jakob Lykke PoulsenAsbjørn Mohr Drewes
Oct 31, 2002·Palliative Medicine·P Good, B Stafford
Oct 19, 2007·Palliative Medicine·Paul W KeeleySimon I R Noble
Apr 21, 2017·The American Journal of Hospice & Palliative Care·Leah Sera, Mary Lynn McPherson
Mar 14, 2007·International Journal of Palliative Nursing·Gaye Kyle
Sep 15, 2004·International Journal of Palliative Nursing·Maria Friedrichsen, Eva Erichsen
May 15, 2015·The Cochrane Database of Systematic Reviews·Bridget CandyPatrick Stone
Oct 18, 2005·The American Journal of Hospice & Palliative Care·Stefan Wirz, Eberhard Klaschik
Sep 23, 2014·British Journal of Hospital Medicine·Freya A Rhodes, Elizabeth Carty
Dec 31, 2016·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Stefan Müller-LissnerBart Morlion
May 22, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Susan C McMillan
Jul 20, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Philippa HawleyMonica Gobbo
Dec 20, 2019·Current Treatment Options in Oncology·Ricard MesíaEduardo Pujol
May 22, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Jorge G Avila

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.